Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Obinna P. Iwuchukwu"'
Autor:
Xunyan Ye, Laura S. Angelo, Erin G. Nicholson, Obinna P. Iwuchukwu, Wanderson Cabral de Rezende, Anubama Rajan, Letisha O. Aideyan, Trevor J. McBride, Nanette Bond, Patricia Santarcangelo, Yolanda J. Rayford, Laura Ferlic-Stark, Sonia Fragoso, Zoha Momin, Hongbing Liu, Khanghy Truong, Brianna Lopez, Margaret E. Conner, Andrew P. Rice, Jason T. Kimata, Vasanthi Avadhanula, Pedro A. Piedra
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 in Wuhan, China, and then rapidly spread causing an unprecedented pandemic. A robust serological assay is needed to evaluate vaccine candidates
Externí odkaz:
https://doaj.org/article/287adc1a945542ff96c592c54f90795c
Autor:
Xunyan Ye, Obinna P. Iwuchukwu, Vasanthi Avadhanula, Letisha O. Aideyan, Trevor J. McBride, Laura L. Ferlic-Stark, Kirtida D. Patel, Felipe-Andres Piedra, Dimpy P. Shah, Roy F. Chemaly, Pedro A. Piedra
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Recent studies of human sera showed that the majority of the respiratory syncytial virus (RSV) neutralizing antibodies are directed against pre-fusion conformation of the fusion (F) protein of RSV and revealed the importance of pre-fusion
Externí odkaz:
https://doaj.org/article/996dab431abc43c9b664b9a9f04c66f5
Autor:
Xunyan Ye, Obinna P. Iwuchukwu, Vasanthi Avadhanula, Letisha O. Aideyan, Trevor J. McBride, David M. Henke, Kirtida D. Patel, Felipe-Andres Piedra, Laura S. Angelo, Dimpy P. Shah, Roy F. Chemaly, Pedro A. Piedra
Publikováno v:
Viruses, Vol 13, Iss 6, p 991 (2021)
Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection in infants, the elderly, and immunocompromised patients. RSV antibodies play a role in preventing reinfection and in clearance of RSV, but data regarding the
Externí odkaz:
https://doaj.org/article/38dab72a27894f1695c3f4052e626fe5
Autor:
Xunyan Ye, Wanderson Cabral de Rezende, Obinna Patrick Iwuchukwu, Vasanthi Avadhanula, Laura L. Ferlic-Stark, Kirtida D. Patel, Felipe-Andres Piedra, Dimpy P. Shah, Roy F. Chemaly, Pedro A. Piedra
Publikováno v:
Vaccines, Vol 8, Iss 2, p 192 (2020)
Background: Cleavage of the inactive precursor fusion protein (F0) of respiratory syncytial virus (RSV) at two furin-recognition sites is required for membrane fusion activity, and the cleavage releases the twenty-seven amino acid peptide (p27). Howe
Externí odkaz:
https://doaj.org/article/f2a8d97336064247a1d792a5fc6e6b40
Autor:
Phillip Pinell, Laura Ferlic-Stark, Xunyan Ye, Anne M. Hause, Obinna P. Iwuchukwu, Patricia Santarcangelo, Nanette Bond, Lauren Maurer, Flor M. Munoz, Pedro A. Piedra, Kelly Dao, Maurizio Maccato, Vasanthi Avadhanula, Letisha O. Aideyan, Trevor McBride
Publikováno v:
Vaccine
Objective To describe the clinical presentation and laboratory diagnosis of pregnant women with respiratory syncytial virus (RSV) infection. Methods Pregnant women in their second and third trimester were enrolled during the course of routine prenata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58d3c0317ae968d427dc3a03bc12540
http://europepmc.org/articles/PMC7126758
http://europepmc.org/articles/PMC7126758
Autor:
Kirtida D. Patel, Roy F. Chemaly, Letisha O. Aideyan, Laura S. Angelo, Obinna P. Iwuchukwu, Dimpy P. Shah, David M. Henke, Xunyan Ye, Vasanthi Avadhanula, Trevor McBride, Pedro A. Piedra, Felipe-Andres Piedra
Publikováno v:
Viruses
Volume 13
Issue 6
Viruses, Vol 13, Iss 991, p 991 (2021)
Volume 13
Issue 6
Viruses, Vol 13, Iss 991, p 991 (2021)
Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection in infants, the elderly, and immunocompromised patients. RSV antibodies play a role in preventing reinfection and in clearance of RSV, but data regarding the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9ae56c3dce2a2e57eeb33f18c1b9a6
http://europepmc.org/articles/PMC8228396
http://europepmc.org/articles/PMC8228396
Autor:
Obinna P. Iwuchukwu, Xunyan Ye, Roy F. Chemaly, Vasanthi Avadhanula, Dimpy P. Shah, Pedro A. Piedra, Laura Ferlic-Stark, Felipe-Andres Piedra, Kirtida D. Patel, Wanderson C. Rezende
Publikováno v:
Vaccines, Vol 8, Iss 192, p 192 (2020)
Vaccines
Volume 8
Issue 2
Vaccines
Volume 8
Issue 2
Background: Cleavage of the inactive precursor fusion protein (F0) of respiratory syncytial virus (RSV) at two furin-recognition sites is required for membrane fusion activity, and the cleavage releases the twenty-seven amino acid peptide (p27). Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f289a4b158d4403b9138012bb721c477
https://www.mdpi.com/2076-393X/8/2/192
https://www.mdpi.com/2076-393X/8/2/192
Autor:
Kirtida D. Patel, Roy F. Chemaly, Dimpy P. Shah, Obinna P. Iwuchukwu, Vasanthi Avadhanula, Letisha O. Aideyan, Trevor McBride, Xunyan Ye, Pedro A. Piedra, Laura Ferlic-Stark, Felipe-Andres Piedra
Publikováno v:
The Journal of infectious diseases. 217(8)
Background Most respiratory syncytial virus (RSV) vaccine candidates include fusion (F) protein in different conformations. Antigenic site II found in the different F conformations is the target of palivizumab, the only US Food and Drug Administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d994149ca6de86aaf9448c2c970922
https://pubmed.ncbi.nlm.nih.gov/29365155
https://pubmed.ncbi.nlm.nih.gov/29365155